About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Stem Cell Findings Could Reveal New Treatment for Type-1 Diabetes

by Shirley Johanna on April 4, 2015 at 7:30 PM
Font : A-A+

Stem Cell Findings Could Reveal New Treatment for Type-1 Diabetes

Researchers at University of California San Diego School of Medicine revealed why it is so hard to use stem cells to make liver and pancreatic cells, and their research findings could lead to new treatments for type 1 diabetes.

The chromosomes in the laboratory stem cells take time to open, in the same sequence that occurs during embryonic development. It is not until certain chromosomes reach the open state that they respond to the added growth factors and become liver or pancreatic cells, the researchers said.

Advertisement

Dr. Mike Sander, professor of pediatrics and cellular and molecular medicine, and Director of the Pediatric Diabetes Research Center at UCSD, said, "Our ability to generate liver and pancreatic cells from stem cells has fallen behind the advances we've made for other cell types. So we haven't yet been able to do things like test new drugs on stem cell-derived liver and pancreatic cells. What we have learned is that if we want to make specific cells from stem cells, we need ways to predict how those cells and their chromosomes will respond to the growth factors."

The study found that the chromosomal regions that need to open before a stem cell can fully differentiate are linked to regions where there are variations in certain disease states.
Advertisement

If a person was to inherit a genetic variation in chromosomal region and doesn't open at the right time, the person is more susceptible to a disease affecting that cell type.

The research team is further working to investigate the role of these chromosomal regions and their variations play in diabetes.

The study was funded by the National Institutes of Health, California Institute for Regenerative Medicine, the Helmsley Charitable Trust and Juvenile Diabetes Research Foundation.

Researchers from the University of Pennsylvania, Penn State University and Ludwig Institute for Cancer Research assisted with the study.



Source: Medindia
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Genetics & Stem Cells News

 Stem Cell Treatment Resolves Perianal Fistulas in Crohn's Disease
Can stem cell therapy cure fistula? Yes, treatment with stem cells has had a success rate when used in perianal fistulas due to Crohn's Disease.
First Effective Preclinical Models for Most Common Genetic Cause of Leigh Syndrome
In zebrafish models of SURF1 mitochondrial disease, scientists have discovered drugs to prevent neurological decompensation.
Gene Therapy for Rare Eye Disease
New study advances intravitreal gene therapy platform to develop safe and effective therapies for visual loss in Usher Syndrome, rare disorder.
Autism-associated Mutation: New Insights
The study experiments shed light on a rare example of how autism-associated mutation could altered nuclear dynamics.
How Genomic Variants Could Help Diagnose Rare Genetic Disorders
A genotype-first approach to patient care involves selecting patients with specific genomic variants and then studying their traits and symptoms.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Stem Cell Findings Could Reveal New Treatment for Type-1 Diabetes Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests